Cart
sales@molnova.com
24-Methylene cycloartanyl ferulate
CAS No. 469-36-3
24-Methylene cycloartanyl ferulate( —— )
Catalog No. M32244 CAS No. 469-36-3
24-Methylenecycloartanyl ferulate, a compound belonging to the γ-oryzanol family, demonstrates the ability to enhance parvin-beta expression within human breast cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 268 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Name24-Methylene cycloartanyl ferulate
-
NoteResearch use only, not for human use.
-
Brief Description24-Methylenecycloartanyl ferulate, a compound belonging to the γ-oryzanol family, demonstrates the ability to enhance parvin-beta expression within human breast cancer cells.
-
Description24-Methylenecycloartanyl ferulate, a compound belonging to the γ-oryzanol family, demonstrates the ability to enhance parvin-beta expression within human breast cancer cells. Furthermore, it exhibits potential as an ATP-competitive Akt1 inhibitor, with an EC 50 value of 33.3 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number469-36-3
-
Formula Weight616.91
-
Molecular FormulaC41H60O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 12.5 mg/mL (20.26 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SEA-0400
SEA0400 is a selective inhibitor of the Na+/Ca2+?exchanger.
-
Chromocarbe
Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
-
UC-1728
UC-1728 is an effective rabbit soluble epoxide hydrolase inhibitor (IC50: 2 nM on rabbit liver). Rabbits were treated by subcutaneous injection with the sEH inhibitor (UC1728, 3 mg/kg), or the vehicle control (PEG400) and uveitis was assessed at 6, 24 and 48 h post-intracameral LPS injection using a modified Hackett-McDonald scoring system.?
